×
For best experience we recommend to activate Javascript in your browser.
LGALS8 antibody (AA 1-317)
The Mouse Monoclonal anti-LGALS8 antibody (Clone C3) (ABIN7617877) specifically detects LGALS8 in WB, IHC, ICC and IP.
The antibody is reactive with Human samples.
Catalog No. ABIN7617877
$473.91
Plus shipping costs $50.00
Delivery in 2 to 3 Business Days
Quick Overview for LGALS8 antibody (AA 1-317) (ABIN7617877)
Target
See all LGALS8 Antibodies
LGALS8
(Lectin, Galactoside-Binding, Soluble, 8 (LGALS8))
Reactivity
All reactivities for LGALS8 antibodies
Human
Host
All hosts for LGALS8 antibodies
Mouse
Clonality
All clonalities for LGALS8 antibodies
Monoclonal
Conjugate
All conjugates for LGALS8 antibodies
This LGALS8 antibody is un-conjugated
Application
All applications for LGALS8 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunoprecipitation (IP)
Clone
C3
Product Details anti-LGALS8 Antibody
(hide)
Binding Specificity
All epitopes for LGALS8 antibodies
AA 1-317
Purpose
Galectin 8 (GAL8) Monoclonal Antibody
Sequence
Met1~Trp317
Characteristics
The Galectin 8 (GAL8) Monoclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Protein A + Protein G affinity chromatography
Isotype
IgG1 kappa
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
1 mg/mL
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for LGALS8
(hide)
Target
LGALS8
(Lectin, Galactoside-Binding, Soluble, 8 (LGALS8))
Alternative Name
GAL8
Gene ID
3964
UniProt
O00214
Recently viewed
(hide)
Chat with us , powered by LiveChat